Allurion Technologies (ALUR) Non Operating Investment Income (2023)
Allurion Technologies (ALUR) reported Non Operating Investment Income of -$6000.0 for Q2 2023.
Allurion Technologies (ALUR) Non Operating Investment Income (2023) Analysis & Trends
Allurion Technologies has reported Non Operating Investment Income for 1 years, with the latest figure at -$6000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | - |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | - |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | - |
| 10 | Allurion Technologies | - | - | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -6,000.00 |